Author

Cédric Coulouarn

Centre Eugène MarquisORCID 0000-0002-5692-9586Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Cédric Coulouarn1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Aashreya RavichandraiD· 1 shared Allan PavyiD· 1 shared Carlos Andres Roldan-HernandeziD· 1 shared Corentin LouisiD· 1 shared Ester Gonzalez‐SancheziD· 1 shared Isabel FabregatiD· 1 shared Javier VaqueroiD· 1 shared Josep AmengualiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aashreya RavichandraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ZEB1 regulates BCL2 in cancer-associated fibroblasts to promote cholangiocarcinoma chemoresistance to gemcitabine and cisplatin

Ester Gonzalez‐Sanchez, Marie Vallette, Aashreya Ravichandra, Mirko Minini, Allan Pavy, Josep Amengual, Carlos Andres Roldan-Hernandez, Corentin Louis, Juan José Lozano, Isabel Fabregat, Nathalie Guedj, Valérie Paradis, Cédric Coulouarn, Lynda Aoudjehane, Laura Fouassier, Javier Vaquero

This study shows ZEB1 in cancer-associated fibroblasts regulates BCL2 to promote chemoresistance in cholangiocarcinoma, suggesting BCL2 inhibitors could enhance gemcitabine and cisplatin efficacy.

bioRxiv · Sep 10, 2025 · PreprintCancer Biology